Skip to content Skip to navigation

Monosaccharide inhibitors targeting carbohydrate esterase family 4 de-N-acetylases.

TitleMonosaccharide inhibitors targeting carbohydrate esterase family 4 de-N-acetylases.
Publication TypeJournal Article
Year of Publication2018
AuthorsDiFrancesco, BR, Morrison, ZA, Nitz, M
JournalBioorg Med Chem
Volume26
Issue21
Pagination5631-5643
Date Published2018 11 15
ISSN1464-3391
Abstract

The Carbohydrate Esterase family 4 contains virulence factors which modify peptidoglycan and biofilm-related exopolysaccharides. Despite the importance of this family of enzymes, a potent mechanism-based inhibition strategy has yet to emerge. Based on the postulated tridentate binding mode of the tetrahedral de-N-acetylation intermediate, GlcNAc derivatives bearing metal chelating groups at the 2 and 3 positions were synthesized. These scaffolds include 2-C phosphonate, 2-C sulfonamide, 2-thionoacetamide warheads as well as derivatives bearing thiol, amine and azide substitutions at the 3-position. The inhibitors were assayed against a representative peptidoglycan deacetylase, Pgda from Streptococcus pneumonia, and a representative biofilm-related exopolysaccharide deacetylase, PgaB from Escherichia coli. Of the inhibitors evaluated, the 3-thio derivatives showed weak to moderate inhibition of Pgda. The strongest inhibitor was benzyl 2,3-dideoxy-2-thionoacetamide-3-thio-β-d-glucoside, whose inhibitory potency showed an unexpected dependence on metal concentration and was found to have a partial mixed inhibition mode (K = 2.9 ± 0.6 μM).

DOI10.1016/j.bmc.2018.10.008
Alternate JournalBioorg. Med. Chem.
PubMed ID30344002
Grant List / / CIHR / Canada